Xue Liu

机构：National Sun Yat-sen University, Sun Yat-sen University, Cleveland Clinic Lerner College of Medicine, Sun Yat-sen University Cancer Center, The Ohio State University, Case Western Reserve University · ORCID：0000-0001-9195-5408

发表论文 95 篇 · 总被引 637 次 · h-index 15

代表论文

• Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers (2022 · Frontiers in Molecular Biosciences · 被引 110)
• Harnessing the Lysosomal Sorting Signals of the Cation-Independent Mannose-6-Phosphate Receptor for Targeted Degradation of Membrane Proteins (2023 · Journal of the American Chemical Society · 被引 61)
• SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis (2023 · Redox Biology · 被引 51)
• The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants (2022 · Science Translational Medicine · 被引 44)
• Small mammals in a biodiversity hotspot harbor viruses of emergence risk (2024 · National Science Review · 被引 17)
• A novel phosphorylation site in SARS-CoV-2 nucleocapsid regulates its RNA-binding capacity and phase separation in host cells (2022 · Journal of Molecular Cell Biology · 被引 13)